Correction: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

• Dmitriy Zamarin,
• Howard L Kaufman,
• Dobrin Draganov,
• Sofia R Gameiro,
• Ilio Vitale,
• Sandy Adjemian,
• Aitziber Buqué Martinez,
• Timothy A Chan,
• Richard L Edelson,
• Lucia Gabriele,
• Encouse Golden,
• Kevin J Harrington,
• Dewan Md Sakib Hossain,
• Michael Karin,
• Juan Jose Lasarte,
• Sherene Loi,
• Gwenola Manic,
• Alan A Melcher,
• Karen L Mossman,
• Maria Rescigno,
• Chiara Riganti,
• Antonella Sistigu,
• Bryan E Strauss,
• Kazuki Tatsuno,
• Stefaan W van Gool,
• Peter Vandenabeele

Affiliations

Dmitriy Zamarin

Memorial Sloan Kettering Cancer Center, New York City, New York, USA

Howard L Kaufman

Surgery, Massachusetts General Hospital and Immuneering Corporation, Boston, Massachusetts, USA

Dobrin Draganov

Aff33 Calidi Biotherapeutics San Diego CA USA

Sofia R Gameiro

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Ilio Vitale

IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy

Sandy Adjemian

VIB Center for Inflammation Research (IRC), Ghent, Belgium

Aitziber Buqué Martinez

Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA

Timothy A Chan

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA

Richard L Edelson

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA

Lucia Gabriele

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy

Encouse Golden

Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA

Kevin J Harrington

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK

Dewan Md Sakib Hossain

Merck & Co. Inc, Kenilworth, New Jersey, USA

Michael Karin

Department of Pharmacology and Pathology, University of California at San Diego (UCSD) School of Medicine, La Jolla, California, USA

Juan Jose Lasarte

Program of Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), University of Navarra, Pamplona, Spain

Sherene Loi

Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Gwenola Manic

IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy

Alan A Melcher

The Institute of Cancer Research, London, UK

Karen L Mossman

McMaster University, Hamilton, Ontario, Canada

Maria Rescigno

Humanitas Clinical and Research Center – IRCCS, Rozzano, Italy

Chiara Riganti

Department of Oncology, University of Torino, Torino, Italy

Antonella Sistigu

UOSD Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Bryan E Strauss

Centro de Investigação Translacional em Oncologia/LIM24, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil

Kazuki Tatsuno

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA

Stefaan W van Gool

Immun-Onkologisches Zentrum Köln, Cologne, Germany

Peter Vandenabeele

VIB Center for Inflammation Research (IRC), Ghent, Belgium